LPC
LLY icon

Loeb Partners Corp’s Eli Lilly LLY Stock Holding History

Loeb Partners Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-800
Closed -$104K – 79
2019
Q1 		$104K Sell
800
-10,400
-93% -$1.26M 2.14% 10
2018
Q4 		$1.3M Buy
11,200
+200
+2% +$22.3K 0.6% 45
2018
Q3 		$1.18M Sell
11,000
-10,350
-48% -$1.03M 0.44% 57
2018
Q2 		$1.82M Buy
21,350
+8,950
+72% +$735K 0.46% 62
2018
Q1 		$959K Buy
12,400
+2,300
+23% +$185K 0.42% 61
2017
Q4 		$853K Hold
10,100
– – 0.25% 81
2017
Q3 		$864K Hold
10,100
– – 0.26% 83
2017
Q2 		$831K Sell
10,100
-250
-2% -$20.4K 0.24% 95
2017
Q1 		$871K Hold
10,350
– – 0.26% 89
2016
Q4 		$761K Buy
+10,350
New +$771K 0.26% 86

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loeb Partners Corp's LLY Position: Q2 2019 in Review

Loeb Partners Corp sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 800 shares — an estimated $104K sold.

Loeb Partners Corp first reported a position in LLY in Q4 2016 and held it in 10 quarters. The position peaked at $1.82M in Q2 2018. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Loeb Partners Corp reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 800 Eli Lilly shares in Q2 2019, an estimated $104K.
  • Loeb Partners Corp first reported a position in Eli Lilly in Q4 2016 and held it in 10 quarters.
  • Loeb Partners Corp's Eli Lilly position peaked at $1.82M in Q2 2018.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.